What’s New in Photon Counting CT?

June 29, 2026 · 9 articles · 12 research themes · covering June 22, 2026 – June 29, 2026

Overview

Across this week’s set of papers, photon-counting detector CT (PCD-CT/PCCT) emerges as a platform whose defining advantage is spectral information—enabling material separation (e.g., iodine/gadolinium/calcium), virtual reconstructions (such as virtual non-contrast), and improved discrimination that can translate into better diagnostic specificity in both routine and high-stakes clinical settings.

Several studies and reviews focus on how these capabilities can improve imaging workflows in acute care. Reviews of abdominal and urinary tract emergencies highlight CT’s continued central role while positioning PCCT as an upgrade that may enhance diagnostic confidence through spectral reconstructions and potentially reduce dose. In parallel, cardiovascular-focused work emphasizes that spectral CT’s material discrimination can expand coronary and congenital heart imaging use cases, while CCTA studies in acute coronary syndrome show that the value of CCTA extends beyond stenosis detection to plaque characterization and high-risk feature assessment for prognosis and patient selection for invasive strategies.

Finally, the translational and physics-oriented contributions underscore that PCCT’s impact is not limited to radiology diagnosis. Fundamental work on proton stopping power ratio and range estimation shows how dimensionality in material decomposition can improve accuracy but is bounded by physical constraints—directly informing how to configure PCCT for safer, tighter proton therapy margins. Complementing this, feasibility studies demonstrate dual-contrast and functional imaging potential: one-scan ventilation–perfusion assessment using spectral photon-counting CT with dual contrast agents in rabbits, and dual-contrast arthrography via iodine/gadolinium/calcium separation for more interpretable co-administered contrast. Together, these papers suggest a trajectory from spectral physics to clinically actionable imaging biomarkers across oncology, emergency medicine, cardiology, and radiation therapy planning.

---

Acute Coronary Syndromes: CCTA for Diagnosis/Prognosis

Diagnostic and Prognostic Value of Coronary Computed Tomography Angiography and High-Risk Plaque Assessment in Acute Coronary Syndrome.

This 2026 review studied the diagnostic and prognostic value of coronary computed tomography angiography (CCTA) and high-risk plaque assessment in patients presenting with acute coronary syndrome (ACS). The key finding was that beyond detecting coronary stenosis, CCTA can characterize plaque composition and identify high-risk plaque features that may improve patient selection for invasive coronary angiography and inform prognosis. Clinically, it supports using CCTA not only for anatomy but also for risk stratification in ACS pathways.

Miceli AL, Iroulart JM, Domenech P et al. · Current problems in cardiology · (2026) · View on PubMed ↗

---

Proton Therapy Planning: SPR/Range Estimation with PCCT

Optimal dimensionality and fundamental limits of proton stopping power estimation with photon-counting CT material decomposition.

This physics study evaluated fundamental limits and optimal dimensionality for proton stopping power ratio (SPR) and range estimation using photon-counting CT (PCCT) material decomposition, using Eigentissue decomposition as the core technique. The key finding was that increasing the dimensionality of material decomposition can improve SPR/range estimation accuracy, but there are fundamental constraints that limit achievable performance for proton therapy planning. Scientifically, the work informs how to configure PCCT-based material decomposition for more accurate proton range prediction and reduced treatment margins.

Larsson K, Näsmark T, Andersson J et al. · Physics in medicine and biology · (2026) · View on PubMed ↗ · Free PDF ↗

---

Pulmonary Ventilation–Perfusion Imaging with Spectral/Photon-Counting CT

Simultaneous pulmonary ventilation and perfusion imaging using spectral photon counting CT with xenon and gadolinium-based agents in combination with color K-edge imaging.

This animal feasibility study assessed simultaneous pulmonary ventilation and perfusion imaging using spectral photon-counting CT (SPCCT) with xenon gas and a gadolinium-based ultrasmall rigid platform (USRP) plus color K-edge imaging in five New Zealand white rabbits. The key finding was that color K-edge imaging enabled SPCCT-based separation/visualization of ventilation (xenon wash-in) and perfusion (intravenous gadolinium agent) signals, with phantom work supporting gadolinium quantification accuracy and evaluation of cross-contamination. Translationally, it demonstrates a potential pathway to one-scan ventilation-perfusion assessment using spectral photon-counting CT and dual contrast agents.

Robert A, Poletto S, Erhard K et al. · Diagnostic and interventional imaging · (2026) · View on PubMed ↗ · Free PDF ↗

---

Dual-Contrast Spectral Imaging (Iodine/Gadolinium/Calcium) & K-edge Separation

A pilot study: dual-contrast arthrography using photon-counting detector computed tomography with gadolinium and iodine contrasts.

This pilot study developed a dual-contrast photon-counting detector CT (PCD-CT) material decomposition approach to simultaneously separate and quantify iodine, gadolinium, and calcium for dual-contrast arthrography. The key finding was that using calibration phantoms and an ex vivo pig-tail specimen scanned on a benchtop PCD-CT system, the method enabled spectral/K-edge-based separation and quantification of co-administered iodine and gadolinium (and calcium). Clinically, it supports more accurate dual-contrast arthrography interpretation by overcoming limitations of conventional CT/MRI when iodine and gadolinium cannot be readily separated.

Deng AX, Day J, Masella O et al. · Physics in medicine and biology · (2026) · View on PubMed ↗ · Free PDF ↗

---

Breast Cancer Imaging with PCCT (Iodine Uptake/Subtyping)

Assessment of breast cancer and feasibility of subtyping of breast cancer using thoracoabdominal staging photon-counting detector computed tomography.

This prospective study evaluated thoracoabdominal photon-counting detector CT (PCD-CT) for breast cancer assessment and feasibility of subtyping using iodine uptake as a marker, using breast MRI as the reference standard in 75 women with 79 newly diagnosed breast cancers. The key finding was that cancer visibility and image quality were rated excellent, cancer size on PCD-CT correlated significantly with MRI (p<0.001), and iodine uptake was explored as a potential basis for breast cancer subtyping. Scientifically and clinically, it supports the feasibility of using thoracoabdominal PCD-CT with iodine-based metrics for breast cancer staging and potential subtype characterization.

Neubauer C, Weiß JB, Fuentes MFM et al. · Scientific reports · (2026) · View on PubMed ↗ · Free PDF ↗

---

Emergency Radiology: Abdominal Urinary Tract Imaging with PCCT

Acute Non-Traumatic Urinary Tract Emergencies: The Central Role of CT Imaging and the Emerging Role of Photon-Counting CT.

This 2026 review studied imaging strategies for acute non-traumatic urinary tract emergencies, emphasizing the central role of CT and the emerging role of photon-counting CT (PCCT). The key finding was that CT remains pivotal for diagnosing obstructive, infectious, vascular, hemorrhagic, and urinary leak conditions, while PCCT may further improve diagnostic performance through spectral reconstructions and potential dose/spatial-resolution advantages. Clinically, it frames how PCCT could enhance emergency urinary tract imaging workflows beyond standard CT.

Scaglione M, Masala SA, Di Grezia G et al. · Canadian Association of Radiologists journal = Journal l’Association canadienne des radiologistes · (2026) · View on PubMed ↗ · Free PDF ↗

---

Emergency Radiology: Abdominal Imaging with PCCT

Photon Counting CT in Abdominal Emergency Radiology.

This 2026 review studied the role of photon-counting CT in abdominal emergency radiology, focusing on spectral reconstructions (e.g., iodine maps and virtual non-contrast images), improved spatial resolution, and radiation exposure reduction. The key finding was that PCCT has demonstrated practical benefits in emergency settings for acute conditions and for characterizing incidental masses and renal stones. Clinically, it positions PCCT as an upgrade to standard abdominal CT protocols that can improve diagnostic confidence while potentially reducing dose.

Parrott D, Dane B · Seminars in roentgenology · (2026) · View on PubMed ↗

---

ENT/Temporal Bone Diagnostics: Audiology–CT Correlation

Conductive hearing loss and normal CT: a clinical perspective.

This clinical perspective reviewed literature and provided illustrative cases correlating audiology with photon-counting detector CT in patients with conductive hearing loss but normal temporal bone CT findings. The key finding was that although conductive hearing loss is often assumed to have an explanatory temporal bone CT correlate (e.g., otosclerosis), some patients show no attributable imaging abnormality due to limitations of CT sensitivity and underlying pathophysiology. Clinically, the article emphasizes that a “normal” temporal bone CT does not fully exclude causes of conductive hearing loss and supports integrating audiologic testing with advanced CT approaches when available.

Rao D, Raymond MJ, Breen JT et al. · Neuroradiology · (2026) · View on PubMed ↗

---

Clinical Implementation & Evidence Synthesis for PCD-CT

Photon-counting detector CT in cardiovascular imaging: technical advances, clinical applications, and future perspectives.

This 2026 review studied photon-counting detector CT (PCD-CT) by systematically summarizing technical advances and evidence for cardiovascular imaging applications across populations with coronary artery disease and congenital heart disease. The key finding was that PCD-CT’s spectral capabilities (including spectral CT and improved material discrimination) enable expanded clinical use cases, while current limitations remain in areas such as performance constraints and practical implementation. Scientifically and clinically, the review positions PCD-CT as a next-generation CT platform for coronary and congenital heart imaging with ongoing research needed to address residual limitations.

Hong Z, Yao B, Wu H · The international journal of cardiovascular imaging · (2026) · View on PubMed ↗

---

---

Generated automatically on June 29, 2026. Covers PubMed articles published June 22, 2026 – June 29, 2026. Summaries are AI-generated; always consult the original publication for clinical or research decisions.